Меню
Набор скоро начнётся NCT07463963

Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febrile Urinary Tract Infections Prevention: a Non-inferiority Randomized Controlled Trial

Без фазы С лечением Bladder Cancer Transurethral Resection of the Bladder Urinary Tract Infection Bacterial

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Urine bacterial Culture (UC), No intervention before TURB surgery.
Кому может быть актуально
Состояния в реестре: Bladder Cancer, Transurethral Resection of the Bladder, Urinary Tract Infection Bacterial. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Франция
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Обзор

The main objective of the study is to demonstrate that not performing a systematic UC before the TURB procedure is non-inferior to performing a systematic UC in terms of the incidence of febrile UTIs during the first 30 postoperative days

Подробное описание

Transurethral resection of the bladder (TURB) is a routinely performed surgery in urology (65,000/y in France). Its primary indication is the management of bladder cancer for diagnostic, prognostic, and therapeutic purposes. Currently, both French and European guidelines recommend screening for asymptomatic bacteriuria (ABU) using a urine culture (UC) before TURB. If the UC is positive, antibiotic treatment must be initiated 48 hours before surgery and continued for a maximum of 7 days after the procedure. Theoretically, the purpose of preoperative ABU screening before TURB is to reduce the rate of post-operative urinary tract infections (UTIs). However, there is currently a lack of high-level studies justifying this approach, despite its being a recommended practice. The literature estimates the rate of post-TURB UTIs to be between 2% and 3.7%. In a recent French multicentre retrospective study, the rate of postoperative febrile UTI was 2.3%. This study did not find a significant association between positive pre-operative UC and a post-operative febrile UTI. Moreover, these post-TURB infections are generally of moderate severity (Grade 2 of Clavien-Dindo classification) and do not progress to sepsis. The rate of severe infections is estimated between 0.3% and 0.74%, and no study has yet demonstrated the link between the presence of a positive preoperative UC and an increased risk of postoperative infection. The causality between preoperative UC and postoperative UTIs remains unestablished. According to the TOCUS study, approximately one-third of patients exhibit ABU before undergoing urological surgery, translating to approximately 20,000 patients annually in France. Despite the relatively low rate of post-TURB UTIs and their mild severity, guidelines mandate antibiotic treatment for these patients. Antibiotic resistance is now a daily concern for clinicians and countries alike. A prominent 2014 WHO report emphasized the consequences of antibiotic resistance, including its impact on morbidity, mortality, and societal costs. The risk of entering a post-antibiotic era by 2050 could become a reality if strong measures are not taken immediately. Therefore, we propose a non- inferiority randomized controlled trial to investigate the impact of not performing pre-operative UC before TURB on the incidence of post-TURB febrile UTIs.

Вмешательства

  • Диагностический тест Urine bacterial Culture (UC)
    Performing a systematic UC before the TURB surgery
  • Другое No intervention before TURB surgery
    No Urine Culture before TURB Surgery

Первичные конечные точки

  • Proportion of patients with post-TURB symptomatic febrile Urinary Tract Infection (UTI) [Срок оценки: During the 30 days following TURB surgery.]
Вторичные конечные точки (10)
  • Proportion of patients with postponed TURB surgery [Срок оценки: Between the pre-operative consultation and date of TURB surgery, up to 60 days]
  • Time to surgery (in days), defined by the number of days between the pre-operative consultation and the date of TURB surgery [Срок оценки: Between the pre-operative consultation and the date of TURB surgery, up to 60 days]
  • The hospital length of stay [Срок оценки: Between TURB surgery and day 30 after TURB surgery]
  • Proportion of patients with hospital readmission or postoperative complications [Срок оценки: Within 30 days following the TURB surgery]
  • Proportion of patients with hospital readmission linked to the urinary surgical procedure [Срок оценки: Within 30 days following the TURB surgery]
  • Proportion of patients with systemic UTI among patients with hospital readmission [Срок оценки: Within 30 days following the TURB surgery]
  • Proportion of patients with pre-operative antibiotic prescription for preoperative colonization before the TURB surgery [Срок оценки: Between Visit 0 (pre-operative consultation) and Visit 1(TURB surgery)]
  • Proportion of patients with post-operative antibiotic prescription [Срок оценки: Within 30 days following the TURB surgery]
  • Time to post-TURB infection diagnosis [Срок оценки: Between the TURB surgery and the infection diagnosis date (truncated at day 30)]
  • Overall survival time [Срок оценки: Between TURB surgery and the date of death (censored at day 30)]

Критерии участия

Критерии включения

  • Patient aged 18 or over
  • Scheduled for TURB surgery for a suspected or confirmed diagnosis of bladder tumor
  • Affiliated person or beneficiary of a social security scheme
  • Written informed consent obtained from the participant

Критерии исключения

  • Patient with active UTI
  • Planned combined surgery
  • Patient previously included in this research protocol
  • People benefiting from enhanced protection, namely minors, people deprived of their liberty by judicial or administrative decision, people staying in a health or social institution, adults under legal protection
  • Pregnant or breastfeeding women, women of childbearing age who do not have effective contraception (Combined (estrogen and progestogen containing) hormonal contraception associated with inhibition of ovulation : oral, intravaginal, transdermal; Progestogen-only hormonal contraception associated with inhibition of ovulation : oral, injectable, implantable; Intrauterine device; Intrauterine hormone-releasing system; Bilateral tubal occlusion) or permanent sterilization methods ( hysterectomy, bilateral salpingectomy, bilateral oophorectomy).

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Другое

Центры проведения

Франция · 15 центров
  • Centre Hospitalier Universitaire d'Angers — Angers
  • Centre Hospitalier Universitaire de Grenoble Alpes — Grenoble
  • Centre Hospitalier de Chartres - Hôpital Louis Pasteur — Le Coudray
  • Centre Hospitalier Universitaire de Lille — Lille
  • Hospices Civils de Lyon — Lyon
  • Assistance Publique - Hôpitaux de Marseille - Hôpital Nord — Marseille
  • Centre Hospitalier Intercommunal de Mont de Marsan et du Pays des Sources — Mont-de-Marsan
  • Centre Hospitalier Universitaire de Nantes - Hotel Dieu — Nantes
  • … и ещё 7 центров

Идентификаторы

NCT: NCT07463963 · 2025-A01451-48

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗